Antonino Romano

Dr. Antonino Romano

University of Foggia, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2008 in Gut
Verified
Journal Article
Closed access
PDF file
GSGaetano Serviddio
Gaetano Serviddio
Francesco BellantiFrancesco Bellanti
Francesco Bellanti
RTR Tamborra
R Tamborra
TRT Rollo
T Rollo
NCN Capitanio
N Capitanio
EAE Altomare
E Altomare
Background: The mechanisms of progression from fatty liver to steatohepatitis and cirrhosis are not well elucidated. Mitochondrial dysfunction represents a key factor in the progression of non-alcoholic steatohepatitis (NASH) as mitochondria are the main cellular site of fatty acid oxidation, ATP synthesis and reactive oxygen species (ROS) production. Aims: (1) To evaluate the role of the uncoupling protein 2 in controlling mitochondrial proton leak and ROS production in NASH rats and humans; and (2) to assess the acute liver damage induced by ischaemia–reperfusion in rats with NASH. Methods: Mitochondria were extracted from the livers of NASH humans and rats fed a methionine and choline deficient diet. Proton leak, H 2 O 2 synthesis, reduced glutathione/oxidised glutathione, 4-hydroxy-2-nonenal (HNE)–protein adducts, uncoupling protein-2 (UCP2) expression and ATP homeostasis were evaluated before and after ischaemia–reperfusion injury. Results: NASH mitochondria exhibited an increased rate of proton leak due to upregulation of UCP2. These results correlated with increased production of mitochondrial hydrogen peroxide and HNE–protein adducts, and decreased hepatic ATP content that was not dependent on mitochondrial ATPase dysfunction. The application of an ischaemia–reperfusion protocol to these livers strongly depleted hepatic ATP stores, significantly increased mitochondrial ROS production and impaired ATPase activity. Livers from patients with NASH exhibited UCP2 over-expression and mitochondrial oxidative stress. Conclusions: Upregulation of UCP2 in human and rat NASH liver induces mitochondrial uncoupling, lowers the redox pressure on the mitochondrial respiratory chain and acts as a protective mechanism against damage progression but compromises the liver capacity to respond to additional acute energy demands, such as ischaemia–reperfusion. These findings suggest that UCP2-dependent mitochondria uncoupling is an important factor underlying events leading to NASH and cirrhosis.

31 May 2020 in Cancers
Verified
Journal Article
Open access
PDF file
MSMoris Sangineto
Moris Sangineto
RVRosanna Villani
Rosanna Villani
FCFrancesco Cavallone
Francesco Cavallone
ARAntonino Romano
Antonino Romano
DLDomenico Loizzi
Domenico Loizzi
GSGaetano Serviddio
Gaetano Serviddio
Metabolic reprogramming is critically involved in the development and progression of cancer. In particular, lipid metabolism has been investigated as a source of energy, micro-environmental adaptation, and cell signalling in neoplastic cells. However, the specific role of lipid metabolism dysregulation in hepatocellular carcinoma (HCC) has not been widely described yet. Alterations in fatty acid synthesis, β-oxidation, and cellular lipidic composition contribute to initiation and progression of HCC. The aim of this review is to elucidate the mechanisms by which lipid metabolism is involved in hepatocarcinogenesis and tumour adaptation to different conditions, focusing on the transcriptional aberrations with new insights in lipidomics and lipid zonation. This will help detect new putative therapeutic approaches in the second most frequent cause of cancer-related death.

Verified
Journal Article
Open access
PDF file
VBVidyasagar Naik Bukke
Vidyasagar Naik Bukke
MAMoola Archana
Moola Archana
RVRosanna Villani
Rosanna Villani
ARAntonino Romano
Antonino Romano
AWAgata Wawrzyniak
Agata Wawrzyniak
TCTommaso Cassano
Tommaso Cassano
Alzheimer’s disease (AD) is an age-related dementia and neurodegenerative disorder, characterized by Aβ and tau protein deposition impairing learning, memory and suppressing synaptic plasticity of neurons. Increasing evidence suggests that there is a link between the glucose and glutamate alterations with age that down-regulates glucose utilization reducing glutamate levels in AD patients. Deviations in brain energy metabolism reinforce the development of AD by hampering glutamate levels in the brain. Glutamate is a nonessential amino acid and the major excitatory neurotransmitter synthesized from glucose. Alterations in cerebral glucose and glutamate levels precede the deposition of Aβ plaques. In the brain, over 40% of neuronal synapses are glutamatergic and disturbances in glutamatergic function have been implicated in pathophysiology of AD. Nevertheless, targeting the glutamatergic system seems to be a promising strategy to develop novel, improved therapeutics for AD. Here, we review data supporting the involvement of the glutamatergic system in AD pathophysiology as well as the efficacy of glutamatergic agents in this neurodegenerative disorder. We also discuss exciting new prospects for the development of improved therapeutics for this devastating disorder.

12 March 2008 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
GSGaetano Serviddio
Gaetano Serviddio
Francesco BellantiFrancesco Bellanti
Francesco Bellanti
RTR. Tamborra
R. Tamborra
TRT. Rollo
T. Rollo
ARAntonino Romano
Antonino Romano
EAE. Altomare
E. Altomare

1 July 2009 in International Journal of Immunopathology and Pharmacology
Verified
Journal Article
Closed access
GSGaetano Serviddio
Gaetano Serviddio
ARAntonino Romano
Antonino Romano
AGA. Greco
A. Greco
TRT. Rollo
T. Rollo
Francesco BellantiFrancesco Bellanti
Francesco Bellanti
GVG. Vendemiale
G. Vendemiale
Frailty Syndrome (FS) is a condition described in aging and characterized by physical vulnerability to stress and lack of physiological reserve. In this study we aim to define whether circulating oxidative stress correlates to frailty in terms of glutathione balance and oxidative protein damage. In 62 elderly outpatients, classified as frail patients according to Fried's criteria, evaluation of reduced Glutathione (GSH), Oxidized Glutathione (GSSG), Tumor Necrosis Factor-α (TNF-α), Malonaldehyde- (MDA) and 4-hydroxy-2,3-nonenal- (HNE) protein plasma adducts were performed. A significant increase in the GSSG was observed in patients with FS when compared to non-frail. No difference was shown in the GSH amount, suggesting a glutathione oxidation more than impairment of the synthesis. TNF-α, MDA- and HNE- adducts, were significantly higher in FS as compared to non-frail patients. A logistic regression model correlating FS with redox balance showed a close relationship between glutathione ratio (OR= 1.8, 95% CI=1.2–2.5) and MDA adducts (OR= 2.8, 95% CI= 1.6–4.7) to frailty. Our findings show an association between oxidative imbalance and Frailty Syndrome. GSSG/GSH ratio and plasma protein adducts strongly predict the frailty conditions and seem to be reliable and easily measurable markers in the context of the multidimensional analysis of elderly patients.

1 December 2011 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
GSGaetano Serviddio
Gaetano Serviddio
Francesco BellantiFrancesco Bellanti
Francesco Bellanti
ANNA MARIA GIUDETTIANNA MARIA GIUDETTI
ANNA MARIA GIUDETTI
GGGabriele Vincenzo Gnoni
Gabriele Vincenzo Gnoni
NCNazzareno Capitanio
Nazzareno Capitanio
EAEmanuele Altomare
Emanuele Altomare